$0.073
-0.003[-3.95%]
Last update: 9:57AM Get Real Time Here
Nemaura Medical
(OTCPK:NMRD)Nemaura Medical Stock (OTC:NMRD), Analyst Ratings, Price Targets, Predictions
Nemaura Medical Inc has a consensus price target of $3.25, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., EF Hutton, and EF Hutton on August 21, 2023, July 17, 2023, and March 30, 2023. With an average price target of $4.17 between HC Wainwright & Co., EF Hutton, and EF Hutton, there's an implied 5607.76% upside for Nemaura Medical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
EF Hutton
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Nemaura Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/21/2023 | NMRD | Buy Now | Nemaura Medical | $0.07 | 3324.66% | HC Wainwright & Co. | Yi Chen | $7 → $2.5 | Maintains | Buy | Get Alert |
| 07/17/2023 | NMRD | Buy Now | Nemaura Medical | $0.07 | 5379.45% | EF Hutton | Constantine Davides | $6 → $4 | Maintains | Buy | Get Alert |
| 03/30/2023 | NMRD | Buy Now | Nemaura Medical | $0.07 | 8119.18% | EF Hutton | Constantine Davides | → $6 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | NMRD | Buy Now | Nemaura Medical | $0.07 | 8119.18% | EF Hutton | Constantine Davides | → $6 | Maintains | Buy | Get Alert |
| 02/27/2023 | NMRD | Buy Now | Nemaura Medical | $0.07 | 9489.04% | HC Wainwright & Co. | Yi Chen | $8 → $7 | Maintains | Buy | Get Alert |
| 08/19/2022 | NMRD | Buy Now | Nemaura Medical | $0.07 | 10858.9% | HC Wainwright & Co. | Yi Chen | $12 → $8 | Maintains | Buy | Get Alert |
| 03/29/2022 | NMRD | Buy Now | Nemaura Medical | $0.07 | 16338.36% | HC Wainwright & Co. | Yi Chen | → $12 | Initiates | → Buy | Get Alert |
| 12/02/2021 | NMRD | Buy Now | Nemaura Medical | $0.07 | 10173.97% | EF Hutton | Constantine Davides | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Nemaura Medical (NMRD)?
The latest price target for Nemaura Medical (OTCPK: NMRD) was reported by HC Wainwright & Co. on August 21, 2023. The analyst firm set a price target for $2.50 expecting NMRD to rise to within 12 months (a possible 3324.66% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nemaura Medical (NMRD)?
The latest analyst rating for Nemaura Medical (OTCPK: NMRD) was provided by HC Wainwright & Co., and Nemaura Medical maintained their buy rating.
When was the last upgrade for Nemaura Medical (NMRD)?
There is no last upgrade for Nemaura Medical.
When was the last downgrade for Nemaura Medical (NMRD)?
There is no last downgrade for Nemaura Medical.
When is the next analyst rating going to be posted or updated for Nemaura Medical (NMRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nemaura Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nemaura Medical was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.
Is the Analyst Rating Nemaura Medical (NMRD) correct?
While ratings are subjective and will change, the latest Nemaura Medical (NMRD) rating was a maintained with a price target of $7.00 to $2.50. The current price Nemaura Medical (NMRD) is trading at is $0.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.